Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Lunai Bioworks Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −13 vs. Q1 2026
- Shares held
- 196.2K
- +72.6K (+58.7%) vs. Q1 2026Converted for a 1-for-8 split
- Total value
- $641.0K
- +$237.7K (+59.0%) vs. Q1 2026
- New holders
- 3
- 8 more added
- Sold out
- 16
- 1 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deutsche Bank AG | 1 | $3 | 0.00% | +1+700.0% | AddedConverted for a 1-for-8 split |
| JPMorgan Chase & Co | 6 | $19 | 0.00% | −4−40.7% | ReducedConverted for a 1-for-8 split |
| BNP Paribas Arbitrage, SA | 24 | $78 | 0.00% | +4+19.3% | AddedConverted for a 1-for-8 split |
| Compass Financial Management LLC | 125 | $409 | 0.00% | +125 | New |
| Morgan Stanley | 326 | $1.07K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Group One Trading, L.P. | 544 | $1.78K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Tower Research Capital LLC (TRC) | 1,405 | $4.59K | 0.00% | +817+139.0% | AddedConverted for a 1-for-8 split |
| Royal Bank of Canada | 1,687 | $5.00K | 0.00% | +1,646+4,039.9% | AddedConverted for a 1-for-8 split |
| Vanguard Fiduciary Trust Co | 8,642 | $28.3K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Virtu Financial LLC | 12,863 | $42.0K | 0.00% | +3,466+36.9% | AddedConverted for a 1-for-8 split |
| BlackRock, Inc. | 15,906 | $52.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Vanguard Capital Management LLC | 16,081 | $52.6K | 0.00% | +4,019+33.3% | AddedConverted for a 1-for-8 split |
| Jane Street Group, LLC | 23,683 | $77.4K | 0.00% | +23,683 | New |
| Geode Capital Management, LLC | 24,156 | $79.0K | 0.00% | +1,376+6.0% | AddedConverted for a 1-for-8 split |
| State Street Corp | 37,537 | $122.7K | 0.00% | +33,071+740.5% | AddedConverted for a 1-for-8 split |
| Ground Swell Capital, LLC | 53,211 | $174.0K | 0.19% | +53,211 | New |
| Nine Masts Capital Ltd | 0 | $0 | 0.00% | −12,803−100.0% | Sold outConverted for a 1-for-8 split |
| Citigroup Inc | 0 | $0 | 0.00% | −12,512−100.0% | Sold outConverted for a 1-for-8 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −6,561−100.0% | Sold outConverted for a 1-for-8 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −4,675−100.0% | Sold outConverted for a 1-for-8 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −3,137−100.0% | Sold outConverted for a 1-for-8 split |
| Jump Financial, LLC | 0 | $0 | 0.00% | −2,433−100.0% | Sold outConverted for a 1-for-8 split |
| Scientech Research LLC | 0 | $0 | 0.00% | −1,708−100.0% | Sold outConverted for a 1-for-8 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −1,510−100.0% | Sold outConverted for a 1-for-8 split |
| UBS Group AG | 0 | $0 | 0.00% | −1,430−100.0% | Sold outConverted for a 1-for-8 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −1,270−100.0% | Sold outConverted for a 1-for-8 split |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −542−100.0% | Sold outConverted for a 1-for-8 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −138−100.0% | Sold outConverted for a 1-for-8 split |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −79−100.0% | Sold outConverted for a 1-for-8 split |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold outConverted for a 1-for-8 split |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-8 split |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-8 split |